This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abele, G
Right arrow Articles by Wahren, B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abele, G
Right arrow Articles by Wahren, B

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1987 January; 31(1): 76-80

Inhibiting effect of (RS)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine on varicella-zoster virus replication in cell culture.

G Abele, A Karlström, J Harmenberg, S Shigeta, A Larsson, B Lindborg and B Wahren

ABSTRACT

The activity and mode of action of the new nucleoside analog (RS)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine (2HM-HBG) against varicella-zoster virus (VZV) were determined. In cell culture, replication of different strains of VZV was inhibited to 50% by 0.4 to 0.7 microM 2HM-HBG, while 685 microM was required to inhibit 50% of the DNA synthesis in uninfected human lung fibroblasts. A thymidine kinase-negative VZV strain was not inhibited by 100 microM 2HM-HBG. Inhibition of VZV replication was not reversible after 7 to 14 days of incubation, depending on the multiplicity of VZV. 2HM-HBG was shown to be selectively phosphorylated by purified VZV thymidine kinase, with an inhibition constant of 32.5 microM. The antiviral activity of 2HM-HBG in cell culture was decreased by the addition of deoxythymidine and deoxycytidine but not by other ribo- or deoxyribonucleosides.


Antimicrob Agents Chemother. 1987 January; 31(1): 76-80




This article has been cited by other articles:

  • Ng, T. I., Shi, Y., Huffaker, H. J., Kati, W., Liu, Y., Chen, C.-M., Lin, Z., Maring, C., Kohlbrenner, W. E., Molla, A. (2001). Selection and Characterization of Varicella-Zoster Virus Variants Resistant to (R)-9-[4-Hydroxy-2-(Hydroxymethy)Butyl]Guanine. Antimicrob. Agents Chemother. 45: 1629-1636 [Abstract] [Full Text]  
  • Neyts, J., Andrei, G., De Clercq, E. (1998). The Antiherpesvirus Activity of H2G [(R)-9-[4-Hydroxy-2-(Hydroxymethyl)Butyl]Guanine] Is Markedly Enhanced by the Novel Immunosuppressive Agent Mycophenolate Mofetil. Antimicrob. Agents Chemother. 42: 3285-3289 [Abstract] [Full Text]